Mitochondrial dysfunction in neurodegenerative diseases
- PMID: 22700435
- PMCID: PMC3422529
- DOI: 10.1124/jpet.112.192138
Mitochondrial dysfunction in neurodegenerative diseases
Abstract
Neurodegenerative diseases are a large group of disabling disorders of the nervous system, characterized by the relative selective death of neuronal subtypes. In most cases, there is overwhelming evidence of impaired mitochondrial function as a causative factor in these diseases. More recently, evidence has emerged for impaired mitochondrial dynamics (shape, size, fission-fusion, distribution, movement etc.) in neurodegenerative diseases such as Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, and Alzheimer's disease. Here, we provide a concise overview of the major findings in recent years highlighting the importance of healthy mitochondria for a healthy neuron.
Figures
Similar articles
-
Mitochondrial dynamics, a key executioner in neurodegenerative diseases.Mitochondrion. 2019 Jul;47:151-173. doi: 10.1016/j.mito.2018.11.002. Epub 2018 Nov 5. Mitochondrion. 2019. PMID: 30408594 Review.
-
Role of mitophagy in mitochondrial quality control: Mechanisms and potential implications for neurodegenerative diseases.Pharmacol Res. 2021 Mar;165:105433. doi: 10.1016/j.phrs.2021.105433. Epub 2021 Jan 14. Pharmacol Res. 2021. PMID: 33454337 Review.
-
Mitochondrial dysfunction and oxidative stress in Alzheimer's disease, and Parkinson's disease, Huntington's disease and Amyotrophic Lateral Sclerosis -An updated review.Mitochondrion. 2023 Jul;71:83-92. doi: 10.1016/j.mito.2023.05.007. Epub 2023 Jun 1. Mitochondrion. 2023. PMID: 37269968 Review.
-
Dynamin-related protein 1: A critical protein in the pathogenesis of neural system dysfunctions and neurodegenerative diseases.J Cell Physiol. 2019 Jul;234(7):10032-10046. doi: 10.1002/jcp.27866. Epub 2018 Dec 4. J Cell Physiol. 2019. PMID: 30515821 Review.
-
Mitophagy in Alzheimer's Disease and Other Age-Related Neurodegenerative Diseases.Cells. 2020 Jan 8;9(1):150. doi: 10.3390/cells9010150. Cells. 2020. PMID: 31936292 Free PMC article. Review.
Cited by
-
Amyotrophic lateral sclerosis and the clinical potential of dexpramipexole.Ther Clin Risk Manag. 2012;8:359-66. doi: 10.2147/TCRM.S21981. Epub 2012 Aug 27. Ther Clin Risk Manag. 2012. PMID: 22956874 Free PMC article.
-
Distinct pools of non-glycolytic substrates differentiate brain regions and prime region-specific responses of mitochondria.PLoS One. 2013 Jul 17;8(7):e68831. doi: 10.1371/journal.pone.0068831. Print 2013. PLoS One. 2013. PMID: 23874783 Free PMC article.
-
"Metal elements and pesticides as risk factors for Parkinson's disease - A review".Toxicol Rep. 2021 Mar 10;8:607-616. doi: 10.1016/j.toxrep.2021.03.009. eCollection 2021. Toxicol Rep. 2021. PMID: 33816123 Free PMC article. Review.
-
Abnormal Glucose Metabolism in Alzheimer's Disease: Relation to Autophagy/Mitophagy and Therapeutic Approaches.Neurochem Res. 2015 Dec;40(12):2557-69. doi: 10.1007/s11064-015-1631-0. Epub 2015 Jun 16. Neurochem Res. 2015. PMID: 26077923 Free PMC article. Review.
-
Promise and Pitfalls of Mitochondrial Replacement for Prevention and Cure of Heritable Neurodegenerative Diseases Caused by Deleterious Mutations in Mitochondrial DNA.Front Cell Neurosci. 2016 Sep 23;10:219. doi: 10.3389/fncel.2016.00219. eCollection 2016. Front Cell Neurosci. 2016. PMID: 27721743 Free PMC article. No abstract available.
References
-
- Beal MF. (2005) Mitochondria take center stage in aging and neurodegeneration. Ann Neurol 58:495–505 - PubMed
-
- Beal MF. (2007) Mitochondria and neurodegeneration. Novartis Found Symp 287:zpg183–192; discussion 192–186 - PubMed
-
- Beal MF. (2009) Therapeutic approaches to mitochondrial dysfunction in Parkinson's disease. Parkinsonism Relat Disord 15 (Suppl 3):S189–S194 - PubMed
-
- Beal MF. (2011) Neuroprotective effects of creatine. Amino Acids 40:1305–1313 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical